2006
DOI: 10.2174/157018006776286934
|View full text |Cite
|
Sign up to set email alerts
|

5-Hydroxy-6-Quinaldic Acid as a Novel Molecular Scaffold for HIV-1 Integrase Inhibitors

Abstract: 8-Hydroxy-7-quinaldic acid can be considered as a basic scaffold for all reported styrylquinoline HIV-1 integrase inhibitors. However, when tested in vitro, this compound appeared to be inactive against the enzyme. We have designed and synthesized an improved molecular fragment, i.e. 5-hydroxy-8-nitro-6-quinaldic acid, which appeared to inhibit HIV-1 integrase in vitro.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
27
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(32 citation statements)
references
References 6 publications
1
27
0
Order By: Relevance
“…The increased OH acidity differentiates, for example, compound 3 from the quinoline type cycles. The increased OH acidity favors lower IC 50 values (compare compound 14a with 13c), also according to our previous results [20,21]. The amidation of 10 yields compounds having IC 50 values similar to that of scaffold 10.…”
Section: Resultssupporting
confidence: 83%
See 2 more Smart Citations
“…The increased OH acidity differentiates, for example, compound 3 from the quinoline type cycles. The increased OH acidity favors lower IC 50 values (compare compound 14a with 13c), also according to our previous results [20,21]. The amidation of 10 yields compounds having IC 50 values similar to that of scaffold 10.…”
Section: Resultssupporting
confidence: 83%
“…Table (1) reports inhibition data for scaffolds 7-10 and amides 11-15. Actually, compounds 9 and 10 appeared to inhibit IN better than compound 7, with the IC 50 amounting for 47 and 42 µM [20], respectively. Scaffolds 8 and 8a appeared to have IC 50 values higher than 100 µM.…”
Section: Resultsmentioning
confidence: 97%
See 1 more Smart Citation
“…In spite of numerous RT inhibitors (including the nucleotide RT inhibitors (NRTIs) and non-nucleotide RT inhibitors (NNRTIs) have been discovered and developed, like other anti-HIV-1 inhibitors, effectiveness of currently approved NRTIs and NNRTIs have been hampered because of their severe side effects and the aggravation of viral variants resistant to HIV-1 drug (Boone, 2006;De Clercq, 2002;Sluis-Cremer, Wainberg, Schinazi, 2015;Yu et al, 2011). To circumvent this challenge, there is an urgent require to develop new, efficacy, selective and safe HIV-1 inhibitors having significant potency against drugresistant RT viral strains and less toxicity still remains a high priority for medical research (Huang et al, 2007;Polanski et al, 2006;Safakish et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…7 A series of compounds derived from 8-hydroxyquinolines and styryl quinoline were recently synthesized as potential HIV-1 integrase inhibitors. 8,9 Similarly, isatin β-thiosemicarbazone derivatives were found to demonstrate a range of antiviral activities against Maloney leukemia virus, vaccinia virus [10][11][12][13] and inhibit HIV-1 replication.…”
Section: Introductionmentioning
confidence: 99%